Product Images Tadalafil
View Photos of Packaging, Labels & Appearance
- pdp - 68071 3781 2
- f35596a7-figure-01 - f35596a7 figure 01
- f35596a7-figure-02 - f35596a7 figure 02
- f35596a7-figure-03 - f35596a7 figure 03
- f35596a7-figure-04 - f35596a7 figure 04
- f35596a7-figure-05 - f35596a7 figure 05
- f35596a7-figure-06 - f35596a7 figure 06
- f35596a7-figure-07 - f35596a7 figure 07
- f35596a7-figure-08 - f35596a7 figure 08
- f35596a7-figure-09 - f35596a7 figure 09
Product Label Images
The following 10 images provide visual information about the product associated with Tadalafil NDC 68071-3781 by Nucare Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
pdp - 68071 3781 2
This text appears to be a description of a medication named "Care Pharmaceuticals." It includes information such as the drug's ingredients, dosage (Tadalafil 20mg), lot number, and expiration date. It also mentions the manufacturer's NDC code, serial number, and provides a warning to keep the medication out of reach of children and store it at a controlled temperature of 68-77°F. Additionally, there is a notice to contact a doctor for medical advice on side effects and how to report them to the FDA.*
f35596a7-figure-01 - f35596a7 figure 01
f35596a7-figure-02 - f35596a7 figure 02
This text provides information related to blood pressure measurements taken in different positions (standing and supine) at specific time intervals. The text includes sections on Diastolic and Systolic blood pressure readings for both positions, along with a note referencing a specific procedure or technique. The data seems to be part of a research study or monitoring process involving the observation of blood pressure variations over time.*
f35596a7-figure-03 - f35596a7 figure 03
This text provides information about a study on the effects of Tadalafil 20 mg and doxazosin 8 mg on standing systolic blood pressure, represented in millimeters of mercury (mmHg) over a period of time.*
f35596a7-figure-04 - f35596a7 figure 04
This text appears to be a table displaying different combinations of medications administered at different times (08:00 and 20:00) and their effects on systolic blood pressure (BP). The medications mentioned are 20 mg of tadalafil and 8 mg of doxazosin. The study seems to compare the effects of these medications alone and in combination with each other. The time after administration of tadalafil or placebo seems to be a crucial factor in observing the impact on systolic blood pressure.*
f35596a7-figure-05 - f35596a7 figure 05
f35596a7-figure-06 - f35596a7 figure 06
The text provides information related to the IPSS Total Score for Tadalafil tablets 5 mg compared to a placebo over a duration of treatment in weeks. The data suggests a significant change from baseline with a p-value of less than 0.001.*
f35596a7-figure-07 - f35596a7 figure 07
This text appears to show a comparison between Tadalafil tablets of 5 mg and a placebo over a duration of treatment in weeks. The text also includes a statistical significance marker of *p<0.01.*
f35596a7-figure-08 - f35596a7 figure 08
Not available.*
f35596a7-figure-09 - f35596a7 figure 09
This text provides information on a study comparing Tadalafil tablets 5mg to a placebo, showing statistical significance (p<0.01). The duration of treatment is presented in weeks.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
